Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride safely reduces excessive hair growth in women.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

The X5 Hairlaser might help treat male hair loss, but more research is needed.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Hair restoration surgery can effectively increase pubic hair density, with patient satisfaction and natural results largely depending on the chosen hair pattern and graft design.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

All medications can cause skin rashes, often without a clear cause, and better tests are needed to identify these drug-related skin issues.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.